Creatinine is a kind of waste product produced by the muscles. It is produced as a result of muscle metabolism and is eliminated through the urine. Sometimes, creatinine is produced due to excessive consumption of meat, especially red meat. A creatinine assay indicates the level of creatinine present in the body and the status of the kidney health. 

Generally, the level of creatinine varies from 0.5 to 1.2 milligrams (mg) per deciliter (dL). The level of creatinine varies in male and female and is generally high in males. The normal range of creatinine in the blood are approximately 0.6 to 1.2 milligrams (mg) per deciliter (dL) in adult males and 0.5 to 1.1 milligrams per deciliter in adult females. Beyond this range, any value is indictive of poor glomerular filtration rate and kidney impairment. 

Global creatinine assay market is expected to grow at a formidable rate during the forecast period. The global creatinine assay market is driven by the technological advancements and innovations in the field of kidney function testing on account of the growing number of patients suffering from chronic kidney disease or other renal impairments. Additionally, growing awareness among the population pertaining to adoption of preventive healthcare is further expected to propel the market during forecast years. Furthermore, supportive government initiatives & policies for promoting renal health awareness is anticipated to foster the growth over 2025. 

The global creatinine assay market can be segmented based on disease, method, kit, sample, end user, company and region. Based on disease, the market can be categorized into type 1 diabetes, type 2 diabetes, kidney disease and others. The kidney disease segment is expected to dominate the market during the forecast period. This can be accredited to the increasing prevalence of renal diseases. Additionally, creatinine assay is majorly and more frequently done in kidney disease as compared to diabetes wherein creatinine assay is generally done once or twice a year depending upon the condition. While, in case of any renal disease, the creatinine assay is done on a regular basis.

Regionally, the creatinine assay market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the market during forecast period. This can be attributed to the presence of a large geriatric population base in the country. Additionally, the presence of key players in the region is further expected to propel the market through 2025.  

Major players operating in the global creatinine assay market include BioVision, Thermo Fisher Scientific, Merck, Bioassay Systems, Cell Biolabs, Fujifilm, Quidel Corporation, Enzo Life Sciences, Tulip Diagnostics, Genway Biotech, Crystal Chem, Randox Laboratories, Nova Biomedical, Cayman Chemical, Pfizer, DiaSys Diagnostic Systems, Abbexa, MedTest DX, Roche, Abcam and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global creatinine assay market.
  • To classify and forecast global creatinine assay market based on disease, method, kit, sample, end user, company and regional distribution.
  • To identify drivers and challenges for global creatinine assay market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global creatinine assay market.
  • To identify and analyze the profile of leading players operating in global creatinine assay market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global creatinine assay market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Creatinine assay kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to creatinine assay
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global creatinine assay market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Disease:
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Kidney disease
    • Others
  • Market, By Method:
    • O'Leary modified Jaffe assay
    • Jaffe
    • Enzymatic
  • Market, By Kit:
    • Creatinine-pap test kits
    • ELISA test kits
    • Jaffe’s kinetic test kits
    • Creatinine Colorimetric/Fluorometric Assay Kit
  • Market, By Sample:
    • Serum
    • Urine
    • Cerebrospinal fluid (CSF)
    • Others
  • Market, By End User:
    • Hospitals and clinics
    • Diagnostic laboratories
    • Others
  • Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Singapore
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global creatinine assay market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customer

5.    Global Creatinine Assay Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others)

5.2.2.     By Method (O'Leary modified Jaffe assay, Jaffe, Enzymatic)

5.2.3.     By Kit (Creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits, Creatinine Colorimetric/Fluorometric Assay Kit)

5.2.4.      By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others)

5.2.5.     By End-User (Hospitals and clinics, Diagnostic laboratories, Others)

5.2.6.     By Company (2019)

5.2.7.     By Region

5.3.  Market Attractiveness Index

6.    Asia-Pacific Creatinine Assay Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Disease

6.2.2.     By Method

6.2.3.     By Kit

6.2.4.     By Sample

6.2.5.     By End-User

6.2.6.     By Country

6.3.  Market Attractiveness Index

6.4.  Asia-Pacific: Country Analysis

6.4.1.     China Creatinine Assay Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Disease

6.4.1.2.2.             By Method

6.4.1.2.3.             By Kit

6.4.1.2.4.             By Sample

6.4.1.2.5.             By End-User

6.4.2.     India Creatinine Assay Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Disease

6.4.2.2.2.             By Method

6.4.2.2.3.             By Kit

6.4.2.2.4.             By Sample

6.4.2.2.5.             By End-User

6.4.3.     Japan Creatinine Assay Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Disease

6.4.3.2.2.             By Method

6.4.3.2.3.             By Kit

6.4.3.2.4.             By Sample

6.4.3.2.5.             By End-User

6.4.4.     South Korea Creatinine Assay Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Disease

6.4.4.2.2.             By Method

6.4.4.2.3.             By Kit

6.4.4.2.4.             By Sample

6.4.4.2.5.             By End-User

6.4.5.     Singapore Creatinine Assay Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Disease

6.4.5.2.2.             By Method

6.4.5.2.3.             By Kit

6.4.5.2.4.             By Sample

6.4.5.2.5.             By End-User

6.4.6.     Australia Creatinine Assay Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Disease

6.4.6.2.2.             By Method

6.4.6.2.3.             By Kit

6.4.6.2.4.             By Sample

6.4.6.2.5.             By End-User

7.    Europe Creatinine Assay Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Disease

7.2.2.     By Method

7.2.3.     By Kit

7.2.4.     By Sample

7.2.5.     By End-User

7.2.6.     By Country

7.3.  Market Attractiveness Index

7.4.  Europe: Country Analysis

7.4.1.     France Creatinine Assay Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Disease

7.4.1.2.2.             By Method

7.4.1.2.3.             By Kit

7.4.1.2.4.             By Sample

7.4.1.2.5.             By End-User

7.4.2.     Germany Creatinine Assay Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Disease

7.4.2.2.2.             By Method

7.4.2.2.3.             By Kit

7.4.2.2.4.             By Sample

7.4.2.2.5.             By End-User

7.4.3.     United Kingdom Creatinine Assay Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Disease

7.4.3.2.2.             By Method

7.4.3.2.3.             By Kit

7.4.3.2.4.             By Sample

7.4.3.2.5.             By End-User

7.4.4.     Italy Creatinine Assay Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Disease

7.4.4.2.2.             By Method

7.4.4.2.3.             By Kit

7.4.4.2.4.             By Sample

7.4.4.2.5.             By End-User

8.    North America Creatinine Assay Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Disease

8.2.2.     By Method

8.2.3.     By Kit

8.2.4.     By Sample

8.2.5.     By End-User

8.2.6.     By Country

8.3.  Market Attractiveness Index

8.4.  North America: Country Analysis

8.4.1.     United States Creatinine Assay Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Disease

8.4.1.2.2.             By Method

8.4.1.2.3.             By Kit

8.4.1.2.4.             By Sample

8.4.1.2.5.             By End-User

8.4.2.     Mexico Creatinine Assay Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Disease

8.4.2.2.2.             By Method

8.4.2.2.3.             By Kit

8.4.2.2.4.             By Sample

8.4.2.2.5.             By End-User

8.4.3.     Canada Creatinine Assay Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Disease

8.4.3.2.2.             By Method

8.4.3.2.3.             By Kit

8.4.3.2.4.             By Sample

8.4.3.2.5.             By End-User

9.    South America Creatinine Assay Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Disease

9.2.2.     By Method

9.2.3.     By Kit

9.2.4.     By Sample

9.2.5.     By End-User

9.2.6.     By Country

9.3.  Market Attractiveness Index

9.4.  South America: Country Analysis

9.4.1.     Brazil Creatinine Assay Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Disease

9.4.1.2.2.             By Method

9.4.1.2.3.             By Kit

9.4.1.2.4.             By Sample

9.4.1.2.5.             By End-User

9.4.2.     Argentina Creatinine Assay Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Disease

9.4.2.2.2.             By Method

9.4.2.2.3.             By Kit

9.4.2.2.4.             By Sample

9.4.2.2.5.             By End-User

9.4.3.     Colombia Creatinine Assay Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Disease

9.4.3.2.2.             By Method

9.4.3.2.3.             By Kit

9.4.3.2.4.             By Sample

9.4.3.2.5.             By End-User

10.  Middle East and Africa Creatinine Assay Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Disease

10.2.2.  By Method

10.2.3.  By Kit

10.2.4.  By Sample

10.2.5.  By End-User

10.2.6.  By Country

10.3.              Market Attractiveness Index

10.4.              MEA: Country Analysis

10.4.1.  South Africa Creatinine Assay Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Disease

10.4.1.2.2.           By Method

10.4.1.2.3.           By Kit

10.4.1.2.4.           By Sample

10.4.1.2.5.           By End-User

10.4.2.  Saudi Arabia Creatinine Assay Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Disease

10.4.2.2.2.           By Method

10.4.2.2.3.           By Kit

10.4.2.2.4.           By Sample

10.4.2.2.5.           By End-User

10.4.3.  UAE Creatinine Assay Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Disease

10.4.3.2.2.           By Method

10.4.3.2.3.           By Kit

10.4.3.2.4.           By Sample

10.4.3.2.5.           By End-User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Players Profiled (Leading Companies)

13.2.1.  BioVision

13.2.2.  Thermo Fisher Scientific

13.2.3.  Merck

13.2.4.  Bioassay Systems

13.2.5.  Cell Biolabs

13.2.6.  Fujifilm

13.2.7.  Quidel Corporation

13.2.8.  Enzo Life Sciences

13.2.9.  Tulip Diagnostics

13.2.10.                Genway Biotech

13.2.11.                Crystal Chem

13.2.12.                Randox Laboratories

13.2.13.                Nova Biomedical

13.2.14.                Cayman Chemical

13.2.15.                Pfizer

13.2.16.                DiaSys Diagnostic Systems

13.2.17.                Abbexa

13.2.18.                MedTest DX

13.2.19.                Roche

13.2.20.                Abcam

14.  Strategic Recommendations

15.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com